Study on consequences for interaction of myricetin with canagliflozin: A special attention to pharmacokinetics and pharmacodynamics of drug
The metabolism of most antidiabetic drugs is initiated by Cytochrome P-450 (CYP) enzymes present in the human body. The result of this metabolism can be a formation of either active metabolites or inactive metabolites. There is possibility of alteration in the activity of CYP enzymes due to some phy...
Main Authors: | Naga Raju Kandukoori, Deepika B, Kiranmai Mandava |
---|---|
Format: | Article |
Language: | English |
Published: |
Faculty of Pharmacy, Mahidol University
2023-01-01
|
Series: | Pharmaceutical Sciences Asia |
Subjects: | |
Online Access: | https://pharmacy.mahidol.ac.th/journal/_files/2023-50-1_3.pdf |
Similar Items
-
Pharmacokinetic Interactions between Canagliflozin and Sorafenib or Lenvatinib in Rats
by: Yanjun Cui, et al.
Published: (2022-08-01) -
Population Pharmacokinetic, Pharmacogenetic, and Pharmacodynamic Analysis of Cyclophosphamide in Ethiopian Breast Cancer Patients
by: Jemal Hussien Ahmed, et al.
Published: (2020-04-01) -
Comparative Pharmacokinetics and Tissue Distribution of M10 and Its Metabolite Myricetin in Normal and Dextran-Sodium-Sulfate-Induced Colitis Mice
by: Jianchun Zhao, et al.
Published: (2022-11-01) -
Fast-acting insulin aspart: a review of its pharmacokinetic and pharmacodynamic properties and the clinical consequences
by: Hanne Haahr, et al.
Published: (2020-06-01) -
Ivermectin: Difficulties in resolving pharmacokinetic and pharmacodynamic relationships in onchocerciasis
by: E N Shu, et al.
Published: (2004-01-01)